-- Net sales of $793.9 million negatively impacted by 6 to 9 percentage points versus 14-week prior year period; H.P. Acthar® Gel also impacted by lower volumes; Hospital results solid; Specialty Generics segment consistent with guidance --
-- GAAP[1] diluted earnings per share from continuing operations of $0.66; adjusted diluted earnings per share of $1.97 --
-- Third quarter operating cash flow of $226.0 million; free cash flow of $176.3 million --
-- Planned acquisition of Ocera continues to build pipeline, focusing on severe and critical conditions --
-- Legal entity reorganization expected to create one-time tax benefit in excess of $800 million in the fourth quarter of 2017, primarily reducing interest-bearing deferred tax liabilities --
-- Net sales of $793.9 million negatively impacted by 6 to 9...
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
0.035(3.21%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.13 | $1.07 | $3.910M | 3.535M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 27197 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 43578 | 3 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |